Age-related%20macular%20degeneration Management
Follow Up
- Monocular near vision (using Amsler grid) monitoring should be done in each follow-up exam
Schedule of Follow-up
- Non-neovascular age-related macular degeneration (AMD)/Intermediate or Advanced AMD in antioxidant vitamin and mineral supplements
- At 6-24 months after treatment if asymptomatic
- Advise immediate consultation if new symptoms suggestive of choroidal neovascularization (CNV) occurs
- Subfoveal neovascular AMD in Ranibizumab therapy
- Approximately 4 weeks after treatment
- Subsequent return will be based on the clinical findings
- Subfoveal neovascular AMD in Pegaptanib sodium therapy
- Every 6 weeks with retreatments as indicated
- Subfoveal neovascular AMD after photodynamic therapy (PDT) with Verteporfin
- Every 3 months until stable, with retreatments as indicated
- Extrafoveal neovascular AMD after laser photocoagulation therapy
- At 2-4 weeks after treatment with fundus fluorescein angiography (FFA) and then 4-6 weeks thereafter